— Agilent Technologies, Inc. (NYSE: A) reported its first-quarter 2020 adjusted earnings of $0.81 per share, up 7% year-over-year. This came in line with the analysts’ expectations.
— Revenue grew by 5.7% to $1.36 billion versus $1.35 billion expected.
— Life Sciences and Applied Markets Group sales rose 5% on continued strength in Environmental & Forensics markets and stable Chemical & Energy.
— Agilent CrossLab Group grew by 6% on continued performance across both services and consumables.
— Diagnostics and Genomics Group saw 6% growth aided by continued strong Nucleic Acids Solutions Division, high single-digit growth in the Next-Generation Sequencing portfolio and mid-single-digit growth in Pathology related businesses.
— Looking ahead into the second quarter of 2020, the company expects revenue in the range of $1.28-1.32 billion and adjusted earnings of $0.72-0.76 per share. Analysts expect EPS of $0.79 on revenue of $1.34 billion.
— The estimated impact of Coronavirus in China of about $10 million revenue deferred into Q2, mostly in Life Sciences and Applied Markets Group.
— For the full year 2020, the company still predicts revenue in the range of $5.50-5.55 billion and adjusted earnings of $3.38-3.43 per share. The consensus estimates EPS of $3.42 on revenue of $5.54 billion.
Most Popular
General Mills (GIS) Q4 Earnings: Key financials and quarterly highlights
General Mills Inc. (NYSE: GIS) reported fourth quarter 2022 earnings results today. Net sales increased 8% year-over-year to $4.9 billion. Organic net sales rose 13%. Net earnings attributable to General
KB Home (KBH): A look at the homebuilder’s expectations for the year
Shares of KB Home (NYSE: KBH) have dropped 35% year-to-date and 28% over the past 12 months. Last week, the company reported second quarter 2022 earnings results that surpassed expectations
Trade Desk’s stock can strengthen your investment portfolio. Here’s why
Trade Desk, Inc. (NASDAQ: TTD) has remained a much sought-after demand-side platform despite challenging market conditions and growing inflationary pressure, but its stock suffered heavy selling in recent months. The
